In vitro experiments corroborated the bioinformatics findings, demonstrating that ASCL1 overexpression accelerates BC progression by enhancing cell proliferation, migration, and invasion, whereas ASCL1 inhibition yields the opposite effects. Here, ASCL1 is linked to breast cancer.